Classes > organic tricyclic compound
Page last updated: 2024-08-05 11:22:46
organic tricyclic compound
null
ChEBI ID: 51959
Members (13)
Member | Definition | Role |
10-hydroxyamitriptyline | | E-10-Hydroxyamitriptyline |
2-(trifluoromethylsulfonyl)-6,11-dihydro-5H-dibenzo[1,3-e-1',2'-f][7]annulen-11-ol | | 2-(trifluoromethylsulfonyl)-6,11-dihydro-5H-dibenzo[1,3-e:1',2'-f][7]annulen-11-ol |
2-bromo-5,6-dihydrodibenzo[3,1-[7]annulen-11-one | | 2-bromo-5,6-dihydrodibenzo[3,1-[7]annulen-11-one |
3-(11-dibenzo[1,2-a-1',2'-e][7]annulenylidene)-N-methyl-1-propanamine | | 3-(11-dibenzo[1,2-a:1',2'-e][7]annulenylidene)-N-methyl-1-propanamine |
amitriptyline hydrochloride | | Amitriptyline hydrochloride |
amitriptyline n-oxide | | amitriptylinoxide |
dibenzheptropine | | (1S,5R)-3-(6,11-dihydro-5H-dibenzo[1,2-a:1',2'-e][7]annulen-11-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane |
evadyne | | butriptyline |
N2,N2,N9,N9-tetramethyl-11-oxo-5,6-dihydrodibenzo[3,1-b-3',1'-f][7]annulene-2,9-disulfonamide | | N2,N2,N9,N9-tetramethyl-11-oxo-5,6-dihydrodibenzo[3,1-b:3',1'-f][7]annulene-2,9-disulfonamide |
N2,N9-dimethyl-11-oxo-5,6-dihydrodibenzo[3,1-b-3',1'-f][7]annulene-2,9-disulfonamide | | N2,N9-dimethyl-11-oxo-5,6-dihydrodibenzo[3,1-b:3',1'-f][7]annulene-2,9-disulfonamide |
nortriptyline | An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline. | nortriptyline |
nortriptyline hydrochloride | | Nortriptyline hydrochloride |
noxiptilin | | noxiptiline |
Research
Studies (2,230)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
pre-1990 | 1,064 (47.71) | 18.7374 |
1990's | 392 (17.58) | 18.2507 |
2000's | 383 (17.17) | 29.6817 |
2010's | 315 (14.13) | 24.3611 |
2020's | 76 (3.41) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
Trials | 535 (21.69%) | 5.53% |
Reviews | 157 (6.36%) | 6.00% |
Case Studies | 223 (9.04%) | 4.05% |
Observational | 3 (0.12%) | 0.25% |
Other | 1,549 (62.79%) | 84.16% |